Furthermore, after bradykinin stimulation, fibroblasts from WS patients release lower amounts of Ca2+ from the ER compared to control samples [67], indicating the loss of bradykinin receptor sensitivity and NCX1 activity. Here, SLC8A1 is linked to Werner syndrome.